125
Participants
Start Date
April 30, 2010
Primary Completion Date
August 31, 2015
Study Completion Date
September 30, 2016
Paclitaxel eluting stent
Patients are randomized to either stenting the moderate SVG lesion with the paclitaxel stent or standard medical treatment
Institut universitaire de cardiologie et de pneumologie de Québec, Québec
Collaborators (1)
Boston Scientific Corporation
INDUSTRY
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
OTHER